XML 41 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:    
Net loss $ (7,122,135) $ (3,119,343)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 18,298 8,668
Amortization 191,177 114,215
Accretion of deferred financing costs 864,921   
Provision for bad debt expense 150,000 54,396
Change in estimated fair value of derivative (1,361,597)   
Amortization of debt discount 1,332,543   
Stock issued to founders    855
Fair value of stock issued for services 401,341 276,300
Stock based compensation 794,165 163,055
Accounts receivable (194,159) (185,305)
Inventory (223,882) (785,874)
Prepaid expenses and other current assets (322,718) (268,716)
Other assets 3,948 (3,948)
Accounts payable and accrued expenses 76,210 (306,692)
Net cash used in operating activities (5,391,888) (4,052,389)
Cash flows from investing activities:    
Change in restricted cash (51,795) (81,270)
Purchase of property and equipment (1,298) (7,671)
Purchase of trademarks    (6,849)
Net cash used in investing activities (53,093) (95,790)
Cash flow from financing activities:    
Proceeds from issuance in common stock    3,374,982
Proceeds from issuance of Series B Preferred Stock, net 5,483,144   
Proceeds from convertible notes payable 4,549,000 772,000
Proceeds from term loan 2,000,000   
Deferred financing costs paid (420,813)   
Repayments on convertibles notes payable (2,950,700)   
Repayments on term loan (83,333)   
Net cash provided by financing activities 8,577,298 4,146,982
CASH OF ACQUIRED COMPANY    5,646
NET INCREASE (DECREASE) IN CASH 3,123,317 4,449
CASH - beginning of period 4,449   
CASH - end of period 3,136,766 4,449
SUPPLEMENTAL DISCLOSURES    
Interest paid in cash 211,247   
Non-cash transactions:    
Conversion of preferred stock to common stock 25,304   
Conversion of notes payable and accrued interest to common stock 1,836,253   
Warrants issued as deferred financing costs 444,108   
Warrants issued as debt discount 1,332,543   
Elimination of derivative liability from conversion of debt to preferred stock 64,970   
Warrants issued in connection with Series B Offering $ 1,268,937